WGU C204: MANAGEMENT COMMUNICATION |
PASSED ON FIRST ATTEMPT |LATEST UPDATE WITH
COMPLETE SOLUTION
AT WESTERN GOVERNORS UNIVERSITY
BKM3 Task 1: Portfolio
Section B: Informational Email to External Stakeholders
Selected Scenario: Scenario 2
Company Name: [Your Company Name]
Investor Name: [Fictional Investor Name]
Prepared by: [Your Name]
Course: C204 – Management Communication
Institution: Western Governors University
Date: [Insert Date]
Subject: YOUR COMPANY NAME Awarded Exclusive Contract to Distribute
Nasaquil
Dear FICTIONAL INVESTOR,
I hope you are doing well. I am pleased to share exciting news regarding YOUR
COMPANY NAME and our innovative product, Nasaquil. In our previous discussion, you
mentioned that your investment decision would depend on whether we secured the
distribution contract. I am proud to inform you that we have officially been awarded
the exclusive rights to distribute Nasaquil in the United States.
According to national public health data, approximately 41 million Americans have
experienced influenza in the past decade, with nearly 50,000 flu-related deaths.
Influenza continues to be a serious public health concern, and the demand for
effective treatment options remains strong. Clinical trial results indicate that Nasaquil
significantly reduces both the severity and duration of flu symptoms, positioning it as
a valuable addition to the market.
This exclusive distribution agreement represents a major milestone for OUR COMPANY
NAME. As the sole distributor of Nasaquil in the U.S., we anticipate a substantial
increase in market share, strengthened brand recognition, and enhanced competitive
positioning within the pharmaceutical distribution industry.
PASSED ON FIRST ATTEMPT |LATEST UPDATE WITH
COMPLETE SOLUTION
AT WESTERN GOVERNORS UNIVERSITY
BKM3 Task 1: Portfolio
Section B: Informational Email to External Stakeholders
Selected Scenario: Scenario 2
Company Name: [Your Company Name]
Investor Name: [Fictional Investor Name]
Prepared by: [Your Name]
Course: C204 – Management Communication
Institution: Western Governors University
Date: [Insert Date]
Subject: YOUR COMPANY NAME Awarded Exclusive Contract to Distribute
Nasaquil
Dear FICTIONAL INVESTOR,
I hope you are doing well. I am pleased to share exciting news regarding YOUR
COMPANY NAME and our innovative product, Nasaquil. In our previous discussion, you
mentioned that your investment decision would depend on whether we secured the
distribution contract. I am proud to inform you that we have officially been awarded
the exclusive rights to distribute Nasaquil in the United States.
According to national public health data, approximately 41 million Americans have
experienced influenza in the past decade, with nearly 50,000 flu-related deaths.
Influenza continues to be a serious public health concern, and the demand for
effective treatment options remains strong. Clinical trial results indicate that Nasaquil
significantly reduces both the severity and duration of flu symptoms, positioning it as
a valuable addition to the market.
This exclusive distribution agreement represents a major milestone for OUR COMPANY
NAME. As the sole distributor of Nasaquil in the U.S., we anticipate a substantial
increase in market share, strengthened brand recognition, and enhanced competitive
positioning within the pharmaceutical distribution industry.
